Detalhe da pesquisa
1.
Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.
Addict Biol
; 19(2): 262-71, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22747521
2.
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers.
Subst Abus
; 33(1): 48-59, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22263713
3.
Opioid detoxification via single 7-day application of a buprenorphine transdermal patch: an open-label evaluation.
Psychopharmacology (Berl)
; 198(2): 149-58, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18327673
4.
Evaluation of a transdermal buprenorphine formulation in opioid detoxification.
Addiction
; 102(10): 1648-56, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17854341
5.
Quantitative analysis of naltrexone and 6beta-naltrexol in human, rat, and rabbit plasma by liquid chromatography-electrospray ionization tandem mass spectrometry with application to the pharmacokinetics of Depotrex in rabbits.
J Anal Toxicol
; 31(8): 453-61, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17988459
6.
An injection depot formulation of buprenorphine: extended bio-delivery and effects.
Addiction
; 101(3): 420-32, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16499515
7.
Determination of nalmefene by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
J Anal Toxicol
; 29(3): 169-74, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15842759
8.
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans.
Psychopharmacology (Berl)
; 159(4): 351-60, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11823887
9.
Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.
Drug Alcohol Depend
; 73(1): 11-22, 2004 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-14687955